forked from sadicelik/DrugBank-Web-Scraper
-
Notifications
You must be signed in to change notification settings - Fork 0
/
Copy pathpharmaco-metabolomics-page113_markup.html
297 lines (297 loc) · 82.6 KB
/
pharmaco-metabolomics-page113_markup.html
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
<!DOCTYPE html><html class="turbolinks-progress-bar"><head><meta content="width=device-width, initial-scale=1, shrink-to-fit=no" name="viewport"><meta content="text/html; charset=UTF-8" http-equiv="Content-Type"><meta content="fdhmwDBTGwNPe0lKcJVly7AToLfZYvJ-mtjFAPTMZGs" name="google-site-verification"><meta content="296E0FF6379AE64A0D18C39BB40ECD6E" name="msvalidate.01"><title>Pharmaco-metabolomics | DrugBank Online</title><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-57x57-precomposed.png" sizes="57x57"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-60x60-precomposed.png" sizes="60x60"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-72x72-precomposed.png" sizes="72x72"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-76x76-precomposed.png" sizes="76x76"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-114x114-precomposed.png" sizes="114x114"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-120x120-precomposed.png" sizes="120x120"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-144x144-precomposed.png" sizes="144x144"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-152x152-precomposed.png" sizes="152x152"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-180x180-precomposed.png" sizes="180x180"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon-precomposed.png" sizes="57x57"><link rel="apple-touch-icon" type="image/x-icon" href="/favicons/apple-touch-icon.png" sizes="57x57"><link rel="icon" type="image/png" href="/favicons/favicon-96x96.png" sizes="96x96"><link rel="icon" type="image/png" href="/favicons/favicon-32x32.png" sizes="32x32"><link rel="icon" type="image/png" href="/favicons/favicon-16x16.png" sizes="16x16"><link rel="icon" type="image/png" href="/favicons/favicon.png" sizes="16x16"><link rel="shortcut icon" type="image/x-icon" href="/favicons/favicon.ico"><meta content="#da532c" name="msapplication-TileColor"><meta content="/favicons/mstile-144x144.png" name="msapplication-TileImage"><meta content="#ffffff" name="theme-color"><meta content="DrugBank" name="application-name"><link as="font" crossorigin="" href="/assets/GemeliWeb-Regular-9ccb07b090f3aef673e3b29ba66e2e685ccf3d438e550624d9739f1bd5164cb2.woff2" rel="preload" type="font/woff2"><link as="font" crossorigin="" href="/assets/GemeliWeb-Bold-f344ff98a063f8cb6ac490b132bda4035ecc8984358dfa8d9bd8621fa38744e2.woff2" rel="preload" type="font/woff2"><link as="font" crossorigin="" href="/assets/GemeliWeb-Light-8227f53ee1957ae57cc0c81d1cfecb59238e3fd9d32b1e792432e1f8c81784a1.woff2" rel="preload" type="font/woff2"><link as="style" data-turbolinks-track="true" href="/assets/public_preload-ec9281ddba7498de9953c0f69a4b77e3e6b7f8f23fe47e1c347b028af890fc0e.css" media="all" onload="this.onload=null;this.rel='stylesheet'" rel="stylesheet"><noscript><link href="/assets/public_preload-ec9281ddba7498de9953c0f69a4b77e3e6b7f8f23fe47e1c347b028af890fc0e.css" media="all" rel="stylesheet" /></noscript><link rel="stylesheet" media="all" href="/assets/public-720199d14ecb75df792c22a0b89a1e5817dab39ae1fda73ea0da1c4d7f67510b.css" data-turbolinks-track="true"><script type="text/javascript" async="" src="https://www.googleadservices.com/pagead/conversion_async.js"></script><script type="text/javascript" async="" src="https://snap.licdn.com/li.lms-analytics/insight.min.js"></script><script async="" src="https://g.clarity.ms/s/0.6.27/clarity.js"></script><script src="https://js.hsadspixel.net/fb.js" type="text/javascript" id="hs-ads-pixel-2224137" data-ads-portal-id="2224137" data-ads-env="prod" data-loader="hs-scriptloader" data-hsjs-portal="2224137" data-hsjs-env="prod" data-hsjs-hublet="na1"></script><script src="https://js.hs-banner.com/2224137.js" type="text/javascript" id="cookieBanner-2224137" data-cookieconsent="ignore" data-hs-ignore="true" data-loader="hs-scriptloader" data-hsjs-portal="2224137" data-hsjs-env="prod" data-hsjs-hublet="na1"></script><script src="https://js.hs-analytics.net/analytics/1636198800000/2224137.js" type="text/javascript" id="hs-analytics"></script><script async="" src="//www.google-analytics.com/analytics.js"></script><script async="" src="https://www.clarity.ms/tag/5600r08mxy"></script><script src="/assets/public-27f932f135aadc4b526264005f1d5e85b32bfbdf9c790701e4b7be02cb9db204.js" media="all" data-turbolinks-track="true" defer="defer"></script><script>(function(c,l,a,r,i,t,y){
c[a]=c[a]||function(){(c[a].q=c[a].q||[]).push(arguments)};
t=l.createElement(r);t.async=1;t.src="https://www.clarity.ms/tag/"+i;
y=l.getElementsByTagName(r)[0];y.parentNode.insertBefore(t,y);
})(window, document, "clarity", "script", "5600r08mxy");</script><meta name="csrf-param" content="authenticity_token">
<meta name="csrf-token" content="xAQi9KNGdV5adtSdjYNPuvqcNkDt/aJ9SWrxe66PBZdCfP+TVzJJMhiqrzTT/dgKPo2eodwmfU3tZR+7P1J/Fg=="><style>html.turbolinks-progress-bar::before {
content: '';
position: fixed;
top: 0;
left: 0;
z-index: 2000;
background-color: #0076ff;
height: 3px;
opacity: 0.99;
width: 0%;
transition: width 300ms ease-out, opacity 150ms ease-in;
transform: translate3d(0,0,0);
}</style><script async="" src="https://www.googletagmanager.com/gtag/js?id=AW-704543816"></script><script src="https://googleads.g.doubleclick.net/pagead/viewthroughconversion/704543816/?random=1636199126316&cv=9&fst=1636199126316&num=1&bg=ffffff&guid=ON&resp=GooglemKTybQhCsO&u_h=720&u_w=1280&u_ah=720&u_aw=1280&u_cd=24&u_his=100&u_tz=180&u_java=true&u_nplug=0&u_nmime=0&gtm=2oab31&sendb=1&ig=1&data=event%3Dgtag.config&frm=0&url=https%3A%2F%2Fgo.drugbank.com%2Fpharmaco%2Fmetabolomics%3Fpage%3D113&tiba=Pharmaco-metabolomics%20%7C%20DrugBank%20Online&hn=www.googleadservices.com&async=1&rfmt=3&fmt=4"></script></head><body class="pharmaco-metabolite-regulations-c index-a has-banner"><header><nav class="navbar fixed-top navbar-expand-custom navbar-light" id="main-nav" style="background-color: #ff00b8;"><a class="navbar-brand" href="/"><img style="width: 178px; height: 20px;" src="/assets/logo-white-dd185d748ee0164b8ee8f88df29235cd8cfc7936a3c974589262c667e9294219.svg" alt="Logo white"><div class="online">Online</div></a><button aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation" class="navbar-toggler navbar-toggler-right" data-target="#navbar" data-toggle="collapse" type="button"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbar"><ul class="navbar-nav ml-auto"><li class="nav-item dropdown"><a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">Browse</a><div class="dropdown-menu"><a class="dropdown-item" href="/drugs"><div class="icon-circle drugbank-icon icon-drugs"><svg class="icon" role="img" title="drugs">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#drugs"></use>
</svg>
</div> Drugs</a><a class="dropdown-item" href="/drugs/starred"><div class="icon-circle drugbank-icon icon-star"><svg class="icon" role="img" title="star">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#star"></use>
</svg>
</div> Starred Drugs</a><a class="dropdown-item" href="/categories"><div class="icon-circle drugbank-icon icon-categories"><svg class="icon" role="img" title="categories">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#categories"></use>
</svg>
</div> Categories</a><a class="dropdown-item" href="/pathways"><div class="icon-circle drugbank-icon icon-pathways"><svg class="icon" role="img" title="pathways">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#pathways"></use>
</svg>
</div> Pathways</a><a class="dropdown-item" href="/reactions"><div class="icon-circle drugbank-icon icon-reactions"><svg class="icon" role="img" title="reactions">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#reactions"></use>
</svg>
</div> Drug Reactions</a><a class="dropdown-item" href="/classyfication"><div class="icon-circle drugbank-icon icon-classifications"><svg class="icon" role="img" title="classifications">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#classifications"></use>
</svg>
</div> Drug Classification</a><a class="dropdown-item" href="/targets"><div class="icon-circle drugbank-icon icon-targets"><svg class="icon" role="img" title="targets">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#targets"></use>
</svg>
</div> Drug Targets</a><div class="dropdown-divider"></div><a class="dropdown-item" href="/pharmaco/genomics"><div class="icon-circle drugbank-icon icon-geno-browse"><svg class="icon" role="img" title="geno-browse">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#geno-browse"></use>
</svg>
</div> Pharmaco-genomics</a><a class="dropdown-item" href="/pharmaco/metabolomics"><div class="icon-circle drugbank-icon icon-chemquery"><svg class="icon" role="img" title="chemquery">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#chemquery"></use>
</svg>
</div> Pharmaco-metabolomics</a><a class="dropdown-item" href="/pharmaco/transcriptomics"><div class="icon-circle drugbank-icon icon-interax"><svg class="icon" role="img" title="interax">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#interax"></use>
</svg>
</div> Pharmaco-transcriptomics</a><a class="dropdown-item" href="/pharmaco/proteomics"><div class="icon-circle drugbank-icon icon-interax"><svg class="icon" role="img" title="interax">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#interax"></use>
</svg>
</div> Pharmaco-proteomics</a></div></li><li class="nav-item dropdown"><a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">COVID-19</a><div class="dropdown-menu"><a class="dropdown-item" href="/covid-19"><div class="icon-circle drugbank-icon icon-covid-overview"><svg class="icon" role="img" title="covid-overview">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#covid-overview"></use>
</svg>
</div> Overview</a><a class="dropdown-item" href="/covid-19-vaccination"><div class="icon-circle drugbank-icon icon-covid-vaccination"><svg class="icon" role="img" title="covid-vaccination">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#covid-vaccination"></use>
</svg>
</div> Vaccine Side Effects</a></div></li><li class="nav-item dropdown"><a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">Search</a><div class="dropdown-menu"><a data-no-turbolink="true" class="dropdown-item" href="/structures/search/small_molecule_drugs/structure"><div class="icon-circle drugbank-icon icon-chemquery"><svg class="icon" role="img" title="chemquery">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#chemquery"></use>
</svg>
</div> Chemical Structure</a><a data-no-turbolink="true" class="dropdown-item" href="/structures/search/small_molecule_drugs/mass"><div class="icon-circle drugbank-icon icon-molecular-weight"><svg class="icon" role="img" title="molecular-weight">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#molecular-weight"></use>
</svg>
</div> Molecular Weight</a><a class="dropdown-item" href="/drug-interaction-checker"><div class="icon-circle drugbank-icon icon-interax"><svg class="icon" role="img" title="interax">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#interax"></use>
</svg>
</div> Drug & Food Interactions</a><a class="dropdown-item" data-no-turbolink="true" href="/structures/search/bonds/sequence"><div class="icon-circle drugbank-icon icon-sequence"><svg class="icon" role="img" title="sequence">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#sequence"></use>
</svg>
</div> Target Sequences</a><a class="dropdown-item" data-no-turbolink="true" href="/pharmaco/search"><div class="icon-circle drugbank-icon icon-pathways"><svg class="icon" role="img" title="pathways">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#pathways"></use>
</svg>
</div> Pharmaco-omics</a><a class="dropdown-item" href="/unearth/advanced/drugs"><div class="icon-circle drugbank-icon icon-advanced"><svg class="icon" role="img" title="advanced">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#advanced"></use>
</svg>
</div> Advanced Search</a><div class="dropdown-divider"></div><a class="dropdown-item" href="/spectra/ms/search"><div class="icon-circle drugbank-icon icon-ms"><svg class="icon" role="img" title="ms">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#ms"></use>
</svg>
</div> MS Search</a><a class="dropdown-item" href="/spectra/ms_ms/search"><div class="icon-circle drugbank-icon icon-msms"><svg class="icon" role="img" title="msms">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#msms"></use>
</svg>
</div> MS/MS Search</a><a class="dropdown-item" href="/spectra/c_ms/search"><div class="icon-circle drugbank-icon icon-gcms"><svg class="icon" role="img" title="gcms">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#gcms"></use>
</svg>
</div> GC/MS Search</a><a class="dropdown-item" href="/spectra/nmr_one_d/search"><div class="icon-circle drugbank-icon icon-nmr-1d"><svg class="icon" role="img" title="nmr-1d">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#nmr-1d"></use>
</svg>
</div> 1D NMR Search</a><a class="dropdown-item" href="/spectra/nmr_two_d/search"><div class="icon-circle drugbank-icon icon-nmr-2d"><svg class="icon" role="img" title="nmr-2d">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#nmr-2d"></use>
</svg>
</div> 2D NMR Search</a></div></li><li class="nav-item"><a class="nav-link" href="/drug-interaction-checker">Interaction Checker</a></li><li class="nav-item"><a class="nav-link" href="/releases/latest">Downloads</a></li><li class="nav-item dropdown" role="presentation"><a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">Solutions</a><div class="dropdown-menu"><div class="link-header dropdown-item">Products</div><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/clinical"><div class="icon-pink product-icon drugbank-icon icon-clinical"><svg class="icon" role="img" title="clinical"> <use xlink:href="/assets/plus/icons-cd39e90ea1c71389b36ffc9fc3f485bf2c6ab875ef9ea285614fcbd70cacf943.svg#clinical"> </use></svg></div> Clinical Drug API</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/scientific"><div class="icon-pink product-icon drugbank-icon icon-scientific"><svg class="icon" role="img" title="scientific"> <use xlink:href="/assets/plus/icons-cd39e90ea1c71389b36ffc9fc3f485bf2c6ab875ef9ea285614fcbd70cacf943.svg#scientific"> </use></svg></div> Scientific Drug Data</a><div class="link-header dropdown-item">Industries</div><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/drug_discovery">Drug Discovery</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/drug_repurposing">Drug Repurposing</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/precision_medicine">Precision Medicine</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/machine_learning">Machine Learning</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/telehealth">Telehealth</a><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/use_cases/electronic_medical_records">Electronic Medical Records</a><div class="link-header dropdown-item">Resources</div><a class="dropdown-item" target="_blank" href="https://www.drugbank.com/downloads">White Papers</a></div></li><li class="nav-item dropdown"><a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">About</a><div class="dropdown-menu right-menu"><div class="col-menu"><div class="menu-col"><div class="link-header dropdown-item"><a target="_blank" href="https://dev.drugbank.com/guides/index"><div class=" drugbank-icon icon-help_center"><svg class="icon" role="img" title="help_center"> <use xlink:href="/assets/plus/icons-cd39e90ea1c71389b36ffc9fc3f485bf2c6ab875ef9ea285614fcbd70cacf943.svg#help_center"> </use></svg></div> Help Center</a></div><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/guides/drugbank/citing"><div class="icon-circle drugbank-icon icon-citing"><svg class="icon" role="img" title="citing">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#citing"></use>
</svg>
</div> Citing DrugBank</a><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/guides/faqs"><div class="icon-circle drugbank-icon icon-faq"><svg class="icon" role="img" title="faq">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#faq"></use>
</svg>
</div> DrugBank Online FAQs</a><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/guides/drugbank/searching"><div class="icon-circle drugbank-icon icon-search"><svg class="icon" role="img" title="search">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#search"></use>
</svg>
</div> Searching DrugBank</a><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/guides/drugbank/other_databases"><div class="icon-circle drugbank-icon icon-database"><svg class="icon" role="img" title="database">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#database"></use>
</svg>
</div> Other Databases</a><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/guides/fields/drugs"><div class="icon-circle drugbank-icon icon-data-sources"><svg class="icon" role="img" title="data-sources">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#data-sources"></use>
</svg>
</div> Data Sources</a></div><div class="menu-col"><div class="link-header dropdown-item"><div class=" drugbank-icon icon-quick_link"><svg class="icon" role="img" title="quick_link"> <use xlink:href="/assets/plus/icons-cd39e90ea1c71389b36ffc9fc3f485bf2c6ab875ef9ea285614fcbd70cacf943.svg#quick_link"> </use></svg></div> About</div><a class="dropdown-item" href="/about"><div class="icon-circle drugbank-icon icon-drugbank"><svg class="icon" role="img" title="drugbank">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#drugbank"></use>
</svg>
</div> About DrugBank Online</a><a class="dropdown-item" target="_blank" href="https://dev.drugbank.com/publications"><div class="icon-circle drugbank-icon icon-search"><svg class="icon" role="img" title="search">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#search"></use>
</svg>
</div> DrugBank in Research</a><a class="dropdown-item" href="/stats"><div class="icon-circle drugbank-icon icon-statistics"><svg class="icon" role="img" title="statistics">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#statistics"></use>
</svg>
</div> Statistics</a><a class="dropdown-item" target="_blank" rel="noopener" href="https://blog.drugbank.com/"><div class="icon-circle drugbank-icon icon-news"><svg class="icon" role="img" title="news">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#news"></use>
</svg>
</div> Blog</a><a target="_blank" rel="noopener" class="dropdown-item" href="http://www.wishartlab.com"><div class="icon-circle drugbank-icon icon-wishart"><svg class="icon" role="img" title="wishart">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#wishart"></use>
</svg>
</div> Wishart Research Group</a><a class="dropdown-item" href="/contact"><div class="small-icon icon-circle drugbank-icon icon-paper-plane"><svg class="icon" role="img" title="paper-plane">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#paper-plane"></use>
</svg>
</div> Contact Us</a></div></div></div></li></ul></div></nav><nav class="navbar fixed-top navbar-expand search-bar justify-content-center justify-content-sm-end d-flex"><div class="form-container"><form class="form-inline" action="/unearth/q" accept-charset="UTF-8" method="get"><input name="utf8" type="hidden" value="✓"><div class="search-group d-none d-sm-block" style="margin-right: 0.5rem;"><select name="searcher" id="searcher" class="form-control input-md"><option value="drugs">Drugs</option>
<option value="bio_entities">Targets</option>
<option value="pathways">Pathways</option>
<option value="indications">Indications</option></select> <div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> </div><div class="search-group"><input type="text" name="query" id="query" class="search-query"> <div class="drugbank-icon icon-search"><svg class="icon" role="img" title="search">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#search"></use>
</svg>
</div> </div></form></div><div class="mini-banner banner-holder"><a target="_blank" href="https://blog.drugbank.com/trends-insights-research-spotlight-2021/"><div class="banner-text"><span class="mr-3">Discover published papers by academic researchers that use DrugBank data.</span><span class="banner-link"><span>Read Blog!</span><div class="icon-circle drugbank-icon icon-arrow-right"><svg class="icon" role="img" title="arrow-right">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-right"></use>
</svg>
</div></span></div></a><div class="close-banner"><div class="drugbank-icon icon-cross"><svg class="icon" role="img" title="cross">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#cross"></use>
</svg>
</div></div></div></nav></header><main role="main"><div class="content-container"><div class="content-header d-sm-flex align-items-center"><h1 class="align-self-center mr-auto">Pharmaco-metabolomics<small>Metabolite changes due to the metabolism of pharmaceutical compounds</small></h1><div class="page-actions ml-auto justify-content-sm-end mt-2 mt-sm-0"><a class="btn btn-sm btn-blue ml-sm-3 mr-2 mr-sm-0 mt-1 mb-1" href="/pharmaco/genomics">Pharmaco-genomics</a><a class="btn btn-sm btn-blue ml-sm-3 mr-2 mr-sm-0 mt-1 mb-1 disabled" href="/pharmaco/metabolomics">Pharmaco-metabolomics</a><a class="btn btn-sm btn-blue ml-sm-3 mr-2 mr-sm-0 mt-1 mb-1" href="/pharmaco/transcriptomics">Pharmaco-transcriptomics</a><a class="btn btn-sm btn-blue ml-sm-3 mr-2 mr-sm-0 mt-1 mb-1" href="/pharmaco/proteomics">Pharmaco-proteomics</a><a data-no-turbolink="true" class="btn btn-sm btn-blue ml-sm-3 mr-2 mr-sm-0 mt-1 mb-1" href="/pharmaco/search">Search</a></div></div><form class="metabolite_regulation_search" id="metabolite_regulation_search" action="/pharmaco/metabolomics" accept-charset="UTF-8" method="get"><input name="utf8" type="hidden" value="✓"><div class="container-fluid"><div class="filter-bar row justify-content-start d-flex flex-wrap flex-column flex-sm-row"><div class="advanced-toggle d-flex d-sm-none justify-content-between align-items-center"><h3>Advanced Filter</h3><div class="toggle"><div class="drugbank-icon icon-add"><svg class="icon" role="img" title="add">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#add"></use>
</svg>
</div><div class="drugbank-icon icon-subtract"><svg class="icon" role="img" title="subtract">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#subtract"></use>
</svg>
</div></div></div><div class="advanced-selector justify-content-start d-sm-flex flex-wrap flex-column flex-sm-row"><div class="group-selector d-sm-block"><h3>Filter by Group</h3><input value="or" type="hidden" name="q[g[0]][m]" id="q_g_0__m"><div class="form-check"><label class="button-control button-check-box" for="approved"><input name="q[g[0]][drug_approved_true]" type="hidden" value="all"><input class="button-control-input" id="approved" type="checkbox" value="1" name="q[g[0]][drug_approved_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Approved</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="nutraceutical"><input name="q[g[0]][drug_nutraceutical_true]" type="hidden" value="all"><input class="button-control-input" id="nutraceutical" type="checkbox" value="1" name="q[g[0]][drug_nutraceutical_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Nutraceutical</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="illicit"><input name="q[g[0]][drug_illicit_true]" type="hidden" value="all"><input class="button-control-input" id="illicit" type="checkbox" value="1" name="q[g[0]][drug_illicit_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Illicit</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="investigational"><input name="q[g[0]][drug_investigational_true]" type="hidden" value="all"><input class="button-control-input" id="investigational" type="checkbox" value="1" name="q[g[0]][drug_investigational_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Investigational</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="withdrawn"><input name="q[g[0]][drug_withdrawn_true]" type="hidden" value="all"><input class="button-control-input" id="withdrawn" type="checkbox" value="1" name="q[g[0]][drug_withdrawn_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Withdrawn</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="experimental"><input name="q[g[0]][drug_experimental_true]" type="hidden" value="all"><input class="button-control-input" id="experimental" type="checkbox" value="1" name="q[g[0]][drug_experimental_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Experimental</span></span></label></div></div><div class="availability-selector d-sm-block"><h3>Filter by Market Availability</h3><input value="or" type="hidden" name="q[g[1]][m]" id="q_g_1__m"><div class="form-check"><label class="button-control button-check-box" for="us"><input name="q[g[1]][drug_available_in_us_true]" type="hidden" value="all"><input class="button-control-input" id="us" type="checkbox" value="1" name="q[g[1]][drug_available_in_us_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">U.S.</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="ca"><input name="q[g[1]][drug_available_in_ca_true]" type="hidden" value="all"><input class="button-control-input" id="ca" type="checkbox" value="1" name="q[g[1]][drug_available_in_ca_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">Canada</span></span></label></div><div class="form-check"><label class="button-control button-check-box" for="eu"><input name="q[g[1]][drug_available_in_eu_true]" type="hidden" value="all"><input class="button-control-input" id="eu" type="checkbox" value="1" name="q[g[1]][drug_available_in_eu_true]"><span class="button-control-indicator btn btn-sm"><span class="button-control-description">E.U.</span></span></label></div></div><div class="submit-filter ml-sm-auto pb-sm-0 justify-content-end d-sm-flex pt-2 align-items-end text-center"><div class="submit-buttons mt-2"><a class="btn btn-drugbank-secondary btn-sm mr-2" href="https://go.drugbank.com/pharmaco/metabolomics">Clear</a><input type="submit" name="commit" value="Apply Filter" class="btn btn-drugbank-primary btn-sm" data-disable-with="Apply Filter"></div></div></div></div></div><div class="index-content"><div class="pagination-holder"><div class="page_info">Displaying entries <b>2801 - 2825</b> of <b>3084</b> in total</div><nav><ul class="pagination pagination-sm"><li class="page-item first"><a class="page-link" href="/pharmaco/metabolomics">«</a></li><li class="page-item previous"><a rel="prev" class="page-link" href="/pharmaco/metabolomics?page=112">‹</a></li><li class="page-item disabled"><a class="page-link" href="#">…</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=109">109</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=110">110</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=111">111</a></li><li class="page-item"><a rel="prev" class="page-link" href="/pharmaco/metabolomics?page=112">112</a></li><li class="page-item active"><a remote="false" class="page-link">113</a></li><li class="page-item"><a rel="next" class="page-link" href="/pharmaco/metabolomics?page=114">114</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=115">115</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=116">116</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=117">117</a></li><li class="page-item disabled"><a class="page-link" href="#">…</a></li><li class="page-item next"><a rel="next" class="page-link" href="/pharmaco/metabolomics?page=114">›</a></li><li class="page-item last"><a class="page-link" href="/pharmaco/metabolomics?page=124">»</a></li></ul></nav></div><table class="table-metabolite-regulations table table-bordered"><thead><tr><th>Drug</th><th>Drug Groups</th><th>Metabolite</th><th>Change</th><th>Description</th><th>Reference</th></tr><tr class="table-search-row"><th><input class=" form-control input-md input-tbl-search" type="text" name="q[drug_precise_names_name_cont]" id="q_drug_precise_names_name_cont"></th><th></th><th><input class=" form-control input-md input-tbl-search" type="text" name="q[metabolite_cont]" id="q_metabolite_cont"></th><th><select class=" form-control input-sm input-tbl-search select2-standard" name="q[change_eq]" id="q_change_eq"><option value=""></option>
<option value="increased">increased</option>
<option value="decreased">decreased</option></select></th><th></th><th class="table-search-submit"><div class="btn-group"><button name="button" type="submit" class="table-search-submit btn btn-sm btn-light"><div class="drugbank-icon icon-search-big"><svg class="icon" role="img" title="search-big">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#search-big"></use>
</svg>
</div></button> <a id="table-search-reset" class="btn btn-light btn-sm" href="/pharmaco/metabolomics">Clear</a></div></th></tr></thead><tbody><tr><td><a href="/drugs/DB00334">Olanzapine</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td>Triglycerides</td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Olanzapine <em>increases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26209" data-original-title="Chen VC, Wang TN, Lu ML, Chou JY, Ju PC, Wu JY, Lin ZR, Ji TT, Chou CE, Lee CT, Lai TJ: Weight gain and ghrelin level after olanzapine monotherapy. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):632-5. doi: 10.1016/j.pnpbp.2011.01.010. Epub 2011 Jan 20.">A26209</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26210" data-original-title="Moteshafi H, Zhornitsky S, Brunelle S, Stip E: Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis. Drug Saf. 2012 Oct 1;35(10):819-36. doi: 10.2165/11631510-000000000-00000.">A26210</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25699" data-original-title="Shao P, Ou J, Wu R, Fang M, Chen H, Xu Y, Zhao J: [Effects of ziprasidone and olanzapine on glucose and lipid metabolism in first-episode schizophrenia]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Apr;38(4):365-9. doi: 10.3969/j.issn.1672-7347.2013.04.005.">A25699</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25696" data-original-title="Hu S, Yao M, Peterson BS, Xu D, Hu J, Tang J, Fan B, Liao Z, Yuan T, Li Y, Yue W, Wei N, Zhou W, Huang M, Xu Y: A randomized, 12-week study of the effects of extended-release paliperidone (paliperidone ER) and olanzapine on metabolic profile, weight, insulin resistance, and beta-cell function in schizophrenic patients. Psychopharmacology (Berl). 2013 Nov;230(1):3-13. doi: 10.1007/s00213-013-3073-1. Epub 2013 Apr 5.">A25696</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25752" data-original-title="Zhang S, Lan G: Prospective 8-week trial on the effect of olanzapine, quetiapine, and aripiprazole on blood glucose and lipids among individuals with first-onset schizophrenia. Shanghai Arch Psychiatry. 2014 Dec;26(6):339-46. doi: 10.11919/j.issn.1002-0829.214037.">A25752</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26270" data-original-title="Su KP, Wu PL, Pariante CM: A crossover study on lipid and weight changes associated with olanzapine and risperidone. Psychopharmacology (Berl). 2005 Dec;183(3):383-6. Epub 2005 Oct 21.">A26270</a></li></ul><ul class="list-unstyled table-list"><li><a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9a57a63e-f856-aafa-037a-c08f2fea6496">DailyMed</a></li></ul></td></tr><tr><td><a href="/drugs/DB00248">Cabergoline</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00122">Glucose</a></td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Cabergoline <em>decreases</em> the level of <em>Glucose</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25739" data-original-title="Krysiak R, Okopien B: Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels. Basic Clin Pharmacol Toxicol. 2015 Mar;116(3):251-6. doi: 10.1111/bcpt.12307. Epub 2014 Sep 11.">A25739</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26271" data-original-title="Krysiak R, Okrzesik J, Okopien B: Different Effects of Metformin on the Hypothalamic-Pituitary-Thyroid Axis in Bromocriptine- and Cabergoline-treated Patients with Hashimoto's Thyroiditis and Glucose Metabolism Abnormalities. Exp Clin Endocrinol Diabetes. 2015 Oct;123(9):561-6. doi: 10.1055/s-0035-1564073. Epub 2015 Sep 15.">A26271</a></li></ul></td></tr><tr><td><a href="/drugs/DB00238">Nevirapine</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>Triglycerides</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Nevirapine <em>decreases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26272" data-original-title="Petit JM, Duong M, Masson D, Buisson M, Duvillard L, Bour JB, Brindisi MC, Galland F, Guiguet M, Gambert P, Portier H, Verges B: Serum adiponectin and metabolic parameters in HIV-1-infected patients after substitution of nevirapine for protease inhibitors. Eur J Clin Invest. 2004 Aug;34(8):569-75.">A26272</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25626" data-original-title="Maggi P, Bellacosa C, Carito V, Perilli F, Lillo A, Volpe A, Trillo G, Angiletta D, Regina G, Angarano G: Cardiovascular risk factors in patients on long-term treatment with nevirapine- or efavirenz-based regimens. J Antimicrob Chemother. 2011 Apr;66(4):896-900. doi: 10.1093/jac/dkq507. Epub 2011 Jan 20.">A25626</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25585" data-original-title="Floridia M, Tamburrini E, Anzidei G, Tibaldi C, Guaraldi G, Guerra B, Meloni AM, Vimercati A, Molinari A, Pinnetti C, Dalzero S, Ravizza M: Plasma lipid profile in pregnant women with HIV receiving nevirapine. AIDS Patient Care STDS. 2009 Mar;23(3):147-52.">A25585</a></li></ul></td></tr><tr><td><a href="/drugs/DB00930">Colesevelam</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>LDL cholesterol</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Colesevelam <em>decreases</em> the level of <em>LDL cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25893" data-original-title="Zema MJ: Colesevelam hydrochloride: evidence for its use in the treatment of hypercholesterolemia and type 2 diabetes mellitus with insights into mechanism of action. Core Evid. 2012;7:61-75. doi: 10.2147/CE.S26725. Epub 2012 Jul 12.">A25893</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25848" data-original-title="Zieve FJ, Kalin MF, Schwartz SL, Jones MR, Bailey WL: Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes. Clin Ther. 2007 Jan;29(1):74-83.">A25848</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25849" data-original-title="Bays HE, Goldberg RB, Truitt KE, Jones MR: Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects. Arch Intern Med. 2008 Oct 13;168(18):1975-83. doi: 10.1001/archinte.168.18.1975.">A25849</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25850" data-original-title="Fonseca VA, Rosenstock J, Wang AC, Truitt KE, Jones MR: Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy. Diabetes Care. 2008 Aug;31(8):1479-84. doi: 10.2337/dc08-0283. Epub 2008 May 5.">A25850</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25554" data-original-title="Goldberg RB, Fonseca VA, Truitt KE, Jones MR: Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy. Arch Intern Med. 2008 Jul 28;168(14):1531-40. doi: 10.1001/archinte.168.14.1531.">A25554</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26058" data-original-title="Handelsman Y, Goldberg RB, Garvey WT, Fonseca VA, Rosenstock J, Jones MR, Lai YL, Jin X, Misir S, Nagendran S, Abby SL: Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study. Endocr Pract. 2010 Jul-Aug;16(4):617-28. doi: 10.4158/EP10129.OR.">A26058</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25890" data-original-title="Rosenstock J, Hernandez-Triana E, Handelsman Y, Misir S, Jones MR: Clinical effects of colesevelam in Hispanic subjects with primary hyperlipidemia and prediabetes. Postgrad Med. 2012 Jul;124(4):14-20. doi: 10.3810/pgm.2012.07.2564.">A25890</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25643" data-original-title="Vega GL, Dunn FL, Grundy SM: Effect of colesevelam hydrochloride on glycemia and insulin sensitivity in men with the metabolic syndrome. Am J Cardiol. 2011 Oct 15;108(8):1129-35. doi: 10.1016/j.amjcard.2011.06.011. Epub 2011 Aug 1.">A25643</a></li></ul></td></tr><tr><td><a href="/drugs/DB01061">Azlocillin</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00562">Creatinine</a></td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Azlocillin <em>increases</em> the level of <em>Creatinine</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26273" data-original-title="Parry MF: The safety and tolerance of azlocillin. Arzneimittelforschung. 1985;35(8):1292-4.">A26273</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26274" data-original-title="Lowenbraun S, Fox N, Cunitz D: Azlocillin, cephalothin, and tobramycin therapy in febrile solid tumor patients with chemotherapy-induced leukopenia. Cancer. 1987 Jul 1;60(1):14-7.">A26274</a></li></ul></td></tr><tr><td><a href="/drugs/DB00734">Risperidone</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td>Triglycerides</td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Risperidone <em>increases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26275" data-original-title="Kohen I, Manu P: Rapidly worsening hypertriglyceridemia during treatment with risperidone. Am J Ther. 2010 Mar-Apr;17(2):216-8. doi: 10.1097/MJT.0b013e318197eadf.">A26275</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25510" data-original-title="Murashita M, Inoue T, Kusumi I, Nakagawa S, Itoh K, Tanaka T, Izumi T, Hosoda H, Kangawa K, Koyama T: Glucose and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia. Psychiatry Clin Neurosci. 2007 Feb;61(1):54-8.">A25510</a></li></ul><ul class="list-unstyled table-list"><li><a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1174730-7a95-4bf6-a425-a5bc1836a17a">DailyMed</a></li></ul></td></tr><tr><td><a href="/drugs/DB01432">Cholestyramine</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td>Triglycerides</td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Cholestyramine <em>increases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26110" data-original-title="Garg A, Grundy SM: Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial. Ann Intern Med. 1994 Sep 15;121(6):416-22.">A26110</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A24844" data-original-title="Stein EA, Heimann KW: Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia. S Afr Med J. 1975 Jul 19;49(31):1252-6.">A24844</a></li></ul></td></tr><tr><td><a href="/drugs/DB01224">Quetiapine</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>Triglycerides</td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Quetiapine <em>increases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25443" data-original-title="Meyer JM, Koro CE: The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophr Res. 2004 Sep 1;70(1):1-17.">A25443</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25752" data-original-title="Zhang S, Lan G: Prospective 8-week trial on the effect of olanzapine, quetiapine, and aripiprazole on blood glucose and lipids among individuals with first-onset schizophrenia. Shanghai Arch Psychiatry. 2014 Dec;26(6):339-46. doi: 10.11919/j.issn.1002-0829.214037.">A25752</a></li></ul></td></tr><tr><td><a href="/drugs/DB08983">Etofibrate</a></td><td><span class="badge badge-secondary badge-pill">Experimental</span></td><td>Triglycerides</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Etofibrate <em>decreases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A24992" data-original-title="Dembinska-Kiec A, Kostka-Trabka E, Grodzinska L, Bieron K, Kedzior A, Basista M, Zmuda A, Trabka E, Slawinski M, Czarnecka H: [Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans]. Fortschr Med. 1989 Jul 10;107(20):450-2.">A24992</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A24942" data-original-title="Klosiewicz-Latoszek L, Szostak WB: Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia. Eur J Clin Pharmacol. 1991;40(1):33-41.">A24942</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25679" data-original-title="Hamilton-Craig I, Kostner KM, Woodhouse S, Colquhoun D: Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations. Int J Evid Based Healthc. 2012 Sep;10(3):181-90. doi: 10.1111/j.1744-1609.2012.00275.x.">A25679</a></li></ul></td></tr><tr><td><a href="/drugs/DB01039">Fenofibrate</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>LDL cholesterol</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Fenofibrate <em>decreases</em> the level of <em>LDL cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25869" data-original-title="Zimetbaum P, Frishman WH, Kahn S: Effects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteins. J Clin Pharmacol. 1991 Jan;31(1):25-37.">A25869</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25870" data-original-title="Bruckert E, De Gennes JL, Malbecq W, Baigts F: Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia. Clin Cardiol. 1995 Nov;18(11):621-9.">A25870</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25033" data-original-title="Hunninghake DB, Peters JR: Effect of fibric acid derivatives on blood lipid and lipoprotein levels. Am J Med. 1987 Nov 27;83(5B):44-9.">A25033</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25679" data-original-title="Hamilton-Craig I, Kostner KM, Woodhouse S, Colquhoun D: Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations. Int J Evid Based Healthc. 2012 Sep;10(3):181-90. doi: 10.1111/j.1744-1609.2012.00275.x.">A25679</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A24942" data-original-title="Klosiewicz-Latoszek L, Szostak WB: Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia. Eur J Clin Pharmacol. 1991;40(1):33-41.">A24942</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25872" data-original-title="Roglans N, Bellido A, Rodriguez C, Cabrero A, Novell F, Ros E, Zambon D, Laguna JC: Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver. Clin Pharmacol Ther. 2002 Dec;72(6):692-701.">A25872</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25655" data-original-title="McCullough PA, Ahmed AB, Zughaib MT, Glanz ED, Di Loreto MJ: Treatment of hypertriglyceridemia with fibric acid derivatives: impact on lipid subfractions and translation into a reduction in cardiovascular events. Rev Cardiovasc Med. 2011;12(4):173-85. doi: 10.3909/ricm0619.">A25655</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26017" data-original-title="Milionis HJ, Papakostas J, Kakafika A, Chasiotis G, Seferiadis K, Elisaf MS: Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia. J Clin Pharmacol. 2003 Aug;43(8):825-30.">A26017</a></li></ul></td></tr><tr><td><a href="/drugs/DB01241">Gemfibrozil</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>Triglycerides</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Gemfibrozil <em>decreases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25397" data-original-title="Talpur R, Ward S, Apisarnthanarax N, Breuer-Mcham J, Duvic M: Optimizing bexarotene therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol. 2002 Nov;47(5):672-84.">A25397</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25655" data-original-title="McCullough PA, Ahmed AB, Zughaib MT, Glanz ED, Di Loreto MJ: Treatment of hypertriglyceridemia with fibric acid derivatives: impact on lipid subfractions and translation into a reduction in cardiovascular events. Rev Cardiovasc Med. 2011;12(4):173-85. doi: 10.3909/ricm0619.">A25655</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25869" data-original-title="Zimetbaum P, Frishman WH, Kahn S: Effects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteins. J Clin Pharmacol. 1991 Jan;31(1):25-37.">A25869</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26276" data-original-title="Lilley JS, Linton MF, Fazio S: Oral retinoids and plasma lipids. Dermatol Ther. 2013 Sep-Oct;26(5):404-10. doi: 10.1111/dth.12085.">A26276</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A24944" data-original-title="Nakandakare E, Garcia RC, Rocha JC, Sperotto G, Oliveira HC, Quintao EC: Effects of simvastatin, bezafibrate and gemfibrozil on the quantity and composition of plasma lipoproteins. Atherosclerosis. 1990 Dec;85(2-3):211-7.">A24944</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25033" data-original-title="Hunninghake DB, Peters JR: Effect of fibric acid derivatives on blood lipid and lipoprotein levels. Am J Med. 1987 Nov 27;83(5B):44-9.">A25033</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25679" data-original-title="Hamilton-Craig I, Kostner KM, Woodhouse S, Colquhoun D: Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations. Int J Evid Based Healthc. 2012 Sep;10(3):181-90. doi: 10.1111/j.1744-1609.2012.00275.x.">A25679</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A16950" data-original-title="Farmer JA, Gotto AM Jr: Currently available hypolipidaemic drugs and future therapeutic developments. Baillieres Clin Endocrinol Metab. 1995 Oct;9(4):825-47.">A16950</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26277" data-original-title="Mussoni L, Mannucci L, Sirtori C, Pazzucconi F, Bonfardeci G, Cimminiello C, Notarbartolo A, Scafidi V, Bittolo Bon G, Alessandrini P, Nenci G, Parise P, Colombo L, Piliego T, Tremoli E: Effects of gemfibrozil on insulin sensitivity and on haemostatic variables in hypertriglyceridemic patients. Atherosclerosis. 2000 Feb;148(2):397-406.">A26277</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26006" data-original-title="Snyder S: Comparison of cholesterol-lowering regimens. Am Fam Physician. 1990 Sep;42(3):761-8.">A26006</a></li></ul><ul class="list-unstyled table-list"><li><a href="https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/in-depth/cholesterol-medications/art-20050958">Mayo Clinic</a></li></ul></td></tr><tr><td><a href="/drugs/DB00335">Atenolol</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>Triglycerides</td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Atenolol <em>increases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25695" data-original-title="Wikoff WR, Frye RF, Zhu H, Gong Y, Boyle S, Churchill E, Cooper-Dehoff RM, Beitelshees AL, Chapman AB, Fiehn O, Johnson JA, Kaddurah-Daouk R: Pharmacometabolomics reveals racial differences in response to atenolol treatment. PLoS One. 2013;8(3):e57639. doi: 10.1371/journal.pone.0057639. Epub 2013 Mar 11.">A25695</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25086" data-original-title="Day JL, Metcalfe J, Simpson CN: Adrenergic mechanisms in control of plasma lipid concentrations. Br Med J (Clin Res Ed). 1982 Apr 17;284(6323):1145-8.">A25086</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26278" data-original-title="Satia MC, Shukla ML, Goyal RK: Comparative effects of atenolol versus nifedipine on serum lipids and other biochemical parameters in diabetic and non-diabetic hypertensive subjects. Indian J Physiol Pharmacol. 1995 Jul;39(3):237-41.">A26278</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A24968" data-original-title="Lithell H, Weiner L, Selinus I, Vessby B: A comparison of the effects of bisoprolol and atenolol on lipoprotein concentrations and blood pressure. J Cardiovasc Pharmacol. 1986;8 Suppl 11:S128-33.">A24968</a></li></ul></td></tr><tr><td><a href="/drugs/DB01076">Atorvastatin</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00067">Total cholesterol</a></td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Atorvastatin <em>decreases</em> the level of <em>Total cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26279" data-original-title="Gomez-Gerique JA, Ros E, Olivan J, Mostaza JM, Vilardell M, Pinto X, Civeira F, Hernandez A, da Silva PM, Rodriguez-Botaro A, Zambon D, Lima J, Diaz C, Aristegui R, Sol JM, Chaves J, Hernandez G: Effect of atorvastatin and bezafibrate on plasma levels of C-reactive protein in combined (mixed) hyperlipidemia. Atherosclerosis. 2002 Jun;162(2):245-51.">A26279</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25387" data-original-title="Chan DC, Watts GF, Barrett PH, Beilin LJ, Redgrave TG, Mori TA: Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia. Diabetes. 2002 Aug;51(8):2377-86.">A25387</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25495" data-original-title="Chan DC, Watts GF, Nguyen MN, Barrett PH: Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesity. Am J Clin Nutr. 2006 Jul;84(1):37-43.">A25495</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26129" data-original-title="Lea AP, McTavish D: Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias. Drugs. 1997 May;53(5):828-47.">A26129</a></li></ul></td></tr><tr><td><a href="/drugs/DB08941">Isoxsuprine</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Withdrawn</span></td><td>Free fatty acids</td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Isoxsuprine <em>increases</em> the level of <em>Free fatty acids</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25080" data-original-title="Imura H, Kato Y, Ikeda M, Morimoto M, Yawata M: Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man. J Clin Invest. 1971 May;50(5):1069-79.">A25080</a></li></ul></td></tr><tr><td><a href="/drugs/DB08983">Etofibrate</a></td><td><span class="badge badge-secondary badge-pill">Experimental</span></td><td>HDL cholesterol</td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Etofibrate <em>increases</em> the level of <em>HDL cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A24992" data-original-title="Dembinska-Kiec A, Kostka-Trabka E, Grodzinska L, Bieron K, Kedzior A, Basista M, Zmuda A, Trabka E, Slawinski M, Czarnecka H: [Effectiveness of etofibrate in arteriosclerosis obliterans. Pilot study in hyperlipidemic patients with arteriosclerosis obliterans]. Fortschr Med. 1989 Jul 10;107(20):450-2.">A24992</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25679" data-original-title="Hamilton-Craig I, Kostner KM, Woodhouse S, Colquhoun D: Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations. Int J Evid Based Healthc. 2012 Sep;10(3):181-90. doi: 10.1111/j.1744-1609.2012.00275.x.">A25679</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A24942" data-original-title="Klosiewicz-Latoszek L, Szostak WB: Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia. Eur J Clin Pharmacol. 1991;40(1):33-41.">A24942</a></li></ul></td></tr><tr><td><a href="/drugs/DB01061">Azlocillin</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td><a target="_blank" rel="noopener" href="http://www.hmdb.ca/metabolites/HMDB00586">Potassium</a></td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Azlocillin <em>decreases</em> the level of <em>Potassium</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26273" data-original-title="Parry MF: The safety and tolerance of azlocillin. Arzneimittelforschung. 1985;35(8):1292-4.">A26273</a></li></ul></td></tr><tr><td><a href="/drugs/DB01076">Atorvastatin</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>Triglycerides</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Atorvastatin <em>decreases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25397" data-original-title="Talpur R, Ward S, Apisarnthanarax N, Breuer-Mcham J, Duvic M: Optimizing bexarotene therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol. 2002 Nov;47(5):672-84.">A25397</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25843" data-original-title="Nakamura T, Takano H, Umetani K, Kawabata K, Obata JE, Kitta Y, Kodama Y, Mende A, Ichigi Y, Fujioka D, Saito Y, Kugiyama K: Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome. Atherosclerosis. 2005 Aug;181(2):321-7. Epub 2005 Feb 16.">A25843</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25387" data-original-title="Chan DC, Watts GF, Barrett PH, Beilin LJ, Redgrave TG, Mori TA: Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia. Diabetes. 2002 Aug;51(8):2377-86.">A25387</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25495" data-original-title="Chan DC, Watts GF, Nguyen MN, Barrett PH: Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesity. Am J Clin Nutr. 2006 Jul;84(1):37-43.">A25495</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26129" data-original-title="Lea AP, McTavish D: Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias. Drugs. 1997 May;53(5):828-47.">A26129</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26280" data-original-title="Funatsu T, Kakuta H, Tanaka H, Arai Y, Suzuki K, Miyata K: [Atorvastatin (Lipitor): a review of its pharmacological and clinical profile]. Nihon Yakurigaku Zasshi. 2001 Jan;117(1):65-76.">A26280</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25421" data-original-title="Bilz S, Wagner S, Schmitz M, Bedynek A, Keller U, Demant T: Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia. J Lipid Res. 2004 Jan;45(1):174-85. Epub 2003 Oct 1.">A25421</a></li></ul></td></tr><tr><td><a href="/drugs/DB09064">Ciprofibrate</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td>Triglycerides</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Ciprofibrate <em>decreases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25869" data-original-title="Zimetbaum P, Frishman WH, Kahn S: Effects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteins. J Clin Pharmacol. 1991 Jan;31(1):25-37.">A25869</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25870" data-original-title="Bruckert E, De Gennes JL, Malbecq W, Baigts F: Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia. Clin Cardiol. 1995 Nov;18(11):621-9.">A25870</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25033" data-original-title="Hunninghake DB, Peters JR: Effect of fibric acid derivatives on blood lipid and lipoprotein levels. Am J Med. 1987 Nov 27;83(5B):44-9.">A25033</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25679" data-original-title="Hamilton-Craig I, Kostner KM, Woodhouse S, Colquhoun D: Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations. Int J Evid Based Healthc. 2012 Sep;10(3):181-90. doi: 10.1111/j.1744-1609.2012.00275.x.">A25679</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A16950" data-original-title="Farmer JA, Gotto AM Jr: Currently available hypolipidaemic drugs and future therapeutic developments. Baillieres Clin Endocrinol Metab. 1995 Oct;9(4):825-47.">A16950</a></li></ul></td></tr><tr><td><a href="/drugs/DB00930">Colesevelam</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>LDL cholesterol</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Colesevelam <em>decreases</em> the level of <em>LDL cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26072" data-original-title="Bays H, Jones PH: Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors. Vasc Health Risk Manag. 2007;3(5):733-42.">A26072</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A25645" data-original-title="Bays HE: Colesevelam hydrochloride added to background metformin therapy in patients with type 2 diabetes mellitus: a pooled analysis from 3 clinical studies. Endocr Pract. 2011 Nov-Dec;17(6):933-8. doi: 10.4158/EP11218.OR.">A25645</a></li></ul></td></tr><tr><td><a href="/drugs/DB00649">Stavudine</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td>Triglycerides</td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Stavudine <em>increases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26040" data-original-title="George JA, Venter WD, Van Deventer HE, Crowther NJ: A longitudinal study of the changes in body fat and metabolic parameters in a South African population of HIV-positive patients receiving an antiretroviral therapeutic regimen containing stavudine. AIDS Res Hum Retroviruses. 2009 Aug;25(8):771-81. doi: 10.1089/aid.2008.0308.">A26040</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26096" data-original-title="Rojas C, Coplan PM, Rhodes T, Robertson MN, DiNubile MJ, Guess HA: Indinavir did not further increase mean triglyceride levels in HIV-infected patients treated with nucleoside reverse transcriptase inhibitors: an analysis of three randomized clinical trials. Pharmacoepidemiol Drug Saf. 2003 Jul-Aug;12(5):361-9.">A26096</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26107" data-original-title="Domingo P, Labarga P, Palacios R, Guerro MF, Terron JA, Elias MJ, Santos J, Ruiz MI, Llibre JM: Improvement of dyslipidemia in patients switching from stavudine to tenofovir: preliminary results. AIDS. 2004 Jul 2;18(10):1475-8.">A26107</a></li></ul></td></tr><tr><td><a href="/drugs/DB00625">Efavirenz</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td>Triglycerides</td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Efavirenz <em>increases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25626" data-original-title="Maggi P, Bellacosa C, Carito V, Perilli F, Lillo A, Volpe A, Trillo G, Angiletta D, Regina G, Angarano G: Cardiovascular risk factors in patients on long-term treatment with nevirapine- or efavirenz-based regimens. J Antimicrob Chemother. 2011 Apr;66(4):896-900. doi: 10.1093/jac/dkq507. Epub 2011 Jan 20.">A25626</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26281" data-original-title="Barragan P, Fisac C, Podzamczer D: Switching strategies to improve lipid profile and morphologic changes. AIDS Rev. 2006 Oct-Dec;8(4):191-203.">A26281</a></li></ul></td></tr><tr><td><a href="/drugs/DB01166">Cilostazol</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span></td><td>Triglycerides</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Cilostazol <em>decreases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26282" data-original-title="Hirose T, Kurebayashi S, Kasayama S: Antiplatelet agent cilostazol potentiates adipocyte differentiation of 3T3-L1 cells. Atherosclerosis. 2001 Sep;158(1):19-22.">A26282</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26283" data-original-title="Nakamura N, Hamazaki T, Johkaji H, Minami S, Yamazaki K, Satoh A, Sawazaki S, Urakaze M, Kobayashi M, Osawa H, Yamabe H, Okomura K: Effects of cilostazol on serum lipid concentrations and plasma fatty acid composition in type 2 diabetic patients with peripheral vascular disease. Clin Exp Med. 2003 Feb;2(4):180-4.">A26283</a></li></ul></td></tr><tr><td><a href="/drugs/DB00627">Niacin</a></td><td><span class="badge badge-secondary badge-pill">Approved</span> <span class="badge badge-secondary badge-pill">Investigational</span> <span class="badge badge-secondary badge-pill">Nutraceutical</span></td><td>HDL cholesterol</td><td><span class="text-success"><div class="drugbank-icon icon-arrow-up"><svg class="icon" role="img" title="arrow-up">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-up"></use>
</svg>
</div> increased</span></td><td>Niacin <em>increases</em> the level of <em>HDL cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A26129" data-original-title="Lea AP, McTavish D: Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias. Drugs. 1997 May;53(5):828-47.">A26129</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26006" data-original-title="Snyder S: Comparison of cholesterol-lowering regimens. Am Fam Physician. 1990 Sep;42(3):761-8.">A26006</a></li></ul></td></tr><tr><td><a href="/drugs/DB00248">Cabergoline</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>Triglycerides</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Cabergoline <em>decreases</em> the level of <em>Triglycerides</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A25739" data-original-title="Krysiak R, Okopien B: Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels. Basic Clin Pharmacol Toxicol. 2015 Mar;116(3):251-6. doi: 10.1111/bcpt.12307. Epub 2014 Sep 11.">A25739</a></li></ul></td></tr><tr><td><a href="/drugs/DB00375">Colestipol</a></td><td><span class="badge badge-secondary badge-pill">Approved</span></td><td>LDL cholesterol</td><td><span class="text-danger"><div class="drugbank-icon icon-arrow-down"><svg class="icon" role="img" title="arrow-down">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#arrow-down"></use>
</svg>
</div> decreased</span></td><td>Colestipol <em>decreases</em> the level of <em>LDL cholesterol</em> in the blood</td><td><ul class="list-unstyled table-list"><li><a target="_blank" title="" class="tips" href="/articles/A24844" data-original-title="Stein EA, Heimann KW: Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia. S Afr Med J. 1975 Jul 19;49(31):1252-6.">A24844</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A26284" data-original-title="Tonstad S, Sivertsen M, Aksnes L, Ose L: Low dose colestipol in adolescents with familial hypercholesterolaemia. Arch Dis Child. 1996 Feb;74(2):157-60.">A26284</a></li>
<li><a target="_blank" title="" class="tips" href="/articles/A16950" data-original-title="Farmer JA, Gotto AM Jr: Currently available hypolipidaemic drugs and future therapeutic developments. Baillieres Clin Endocrinol Metab. 1995 Oct;9(4):825-47.">A16950</a></li></ul></td></tr></tbody></table><div class="pagination-holder"><div class="page_info">Displaying entries <b>2801 - 2825</b> of <b>3084</b> in total</div><nav><ul class="pagination pagination-sm"><li class="page-item first"><a class="page-link" href="/pharmaco/metabolomics">«</a></li><li class="page-item previous"><a rel="prev" class="page-link" href="/pharmaco/metabolomics?page=112">‹</a></li><li class="page-item disabled"><a class="page-link" href="#">…</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=109">109</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=110">110</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=111">111</a></li><li class="page-item"><a rel="prev" class="page-link" href="/pharmaco/metabolomics?page=112">112</a></li><li class="page-item active"><a remote="false" class="page-link">113</a></li><li class="page-item"><a rel="next" class="page-link" href="/pharmaco/metabolomics?page=114">114</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=115">115</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=116">116</a></li><li class="page-item"><a class="page-link" href="/pharmaco/metabolomics?page=117">117</a></li><li class="page-item disabled"><a class="page-link" href="#">…</a></li><li class="page-item next"><a rel="next" class="page-link" href="/pharmaco/metabolomics?page=114">›</a></li><li class="page-item last"><a class="page-link" href="/pharmaco/metabolomics?page=124">»</a></li></ul></nav></div></div></form></div></main><footer><div class="row p-3 p-sm-4 m-0"><div class="col-md-5 footer-content"><div class="footer-item footer-commercial"><img style="width: 130px; height: 100px;" src="/assets/plus/Data_Pink-68da9b7525141f098e2e0ebcbd888ce950fe6032fd0da3a227c22117cedd7062.png" alt="Data pink"><h2>Interested in using DrugBank in a <strong>commercial product</strong> or <strong>application?</strong></h2><a class="btn btn-pink-filled" target="_blank" href="https://www.drugbank.com/">Visit DrugBank.com <div class=" drugbank-icon icon-see_more"><svg class="icon" role="img" title="see_more"> <use xlink:href="/assets/plus/icons-cd39e90ea1c71389b36ffc9fc3f485bf2c6ab875ef9ea285614fcbd70cacf943.svg#see_more"> </use></svg></div></a></div><div class="footer-item footer-newsletter hidden" id="newsletter-1"><div class="newsletter-header"><img style="width: 131px; height: 100px;" src="/assets/plus/Article_Dark_Pink-17ef3dc892e28e001abbb0ae6bfc47fca8a64cd76af37ec2a80dbce89fe3bc72.png" alt="Article dark pink"><h2>Stay up-to-date with the <br><strong>latest from DrugBank!</strong></h2></div><form action="https://dev.drugbank.com/contacts" class="form" id="newsletter-form" method="post"><input class="form-control hidden" id="contact_name" name="contact[name]" type="hidden" value="New Subscriber"><input class="form-control hidden" id="contact_mailing_list" name="contact[mailing_list]" type="hidden" value="yes"><input class="form-control hidden" id="data_type" name="data_type" type="hidden" value="json"><input class="form-control hidden" id="contact_address" name="contact[address]" type="hidden"><input class="form-control hidden" name="contact[return_url]" type="hidden" value="https://go.drugbank.com/#newsletter-3"><input class="form-control hidden" name="contact[form_url]" type="hidden" value="https://go.drugbank.com/"><input class="form-control hidden" id="referer" name="contact[referer]" type="hidden" value=""><input class="form-control hidden" id="type" name="contact[type]" type="hidden" value="newsletter"><input class="form-control hidden" id="ga_client_id" name="contact[ga_client_id]" type="hidden" value="1407225613.1636197853"><div class="input-group"><input class="form-control" id="contact_email" name="contact[email]" placeholder="Enter your email" required="" type="text"><span class="input-group-btn"><button class="btn btn-pink-filled" id="subscribe" type="submit">Subscribe</button></span></div><div class="help-block with-errors"></div></form></div><div class="footer-item footer-newsletter hidden" id="newsletter-3"><div class="newsletter-header"><img style="width: 131px; height: 100px;" src="/assets/plus/Article_Dark_Pink-17ef3dc892e28e001abbb0ae6bfc47fca8a64cd76af37ec2a80dbce89fe3bc72.png" alt="Article dark pink"><h2><strong>Thank you</strong> <br>for subscribing!</h2></div></div></div><div class="col-md-7 footer-links"><div class="container"><div class="row footer-row"><div class="col-sm-4 footer-col"><div class="footer-header">About</div><div class="footer-list"><ul class="list-unstyled"><li><a href="/about">About DrugBank Online</a></li><li><a target="_blank" href="https://blog.drugbank.com/">Blog</a></li><li><a target="_blank" href="http://www.wishartlab.com">Wishart Research Group</a></li><li><a href="https://www.drugbank.com/about/careers">Careers</a></li><li><a href="/legal/terms_of_use">Terms of Use</a></li><li><a href="/legal/privacy_policy">Privacy Policy</a></li></ul></div></div><div class="col-sm-4 footer-col"><div class="footer-header">Support</div><div class="footer-list"><ul class="list-unstyled"><li><a target="_blank" href="https://dev.drugbank.com/guides/index">Help Center</a></li><li><a target="_blank" href="https://dev.drugbank.com/guides/faqs">DrugBank Online FAQs</a></li><li><a href="/contact">Contact Support</a></li></ul></div></div><div class="col-sm-4 footer-col"><div class="footer-header"><a href="https://www.drugbank.com/">Commercial Data</a></div><div class="footer-list"><ul class="list-unstyled"><li><a target="_blank" href="https://www.drugbank.com/clinical">Clinical Drug Data</a></li><li><a target="_blank" href="https://www.drugbank.com/scientific">Scientific Drug Data</a></li><li><a target="_blank" href="https://www.drugbank.com/contact/sales?ref=go.drugbank.com%2Fpharmaco%2Fmetabolomics">Contact Sales</a></li></ul></div></div></div><div class="row footer-row"><div class="col-sm-12"><div class="social-media"><a class="social-media-link" href="https://www.linkedin.com/company/drugbank/"><div class="drugbank-icon icon-linkedin"><svg class="icon" role="img" title="linkedin">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#linkedin"></use>
</svg>
</div></a><a class="social-media-link" href="https://twitter.com/DrugBankDB"><div class="drugbank-icon icon-twitter"><svg class="icon" role="img" title="twitter">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#twitter"></use>
</svg>
</div></a><a class="social-media-link" href="https://www.facebook.com/DrugBankDatabase"><div class="drugbank-icon icon-facebook"><svg class="icon" role="img" title="facebook">
<use xlink:href="/assets/icons-b5e582577bf5da72d1df8a7d1b81629eea1cc7deaae8c957adf46f1fbe736051.svg#facebook"></use>
</svg>
</div></a></div><h6>Website design by Educe Design & Innovation Inc.</h6></div></div></div></div></div></footer><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon="{"rayId":"6a9e1357adcdacca","token":"e28ec36f07f74c1ca13c169ca4430981","version":"2021.10.0","si":100}"></script>
<script src="/assets/analytics-1b5960c76af2e5f1a83c45e21ee367baf13121e0a2d42380a71abadf0edaa402.js" media="all" data-turbolinks-track="true"></script><script type="text/javascript" id="hs-script-loader" async="" defer="" src="//js.hs-scripts.com/2224137.js"></script></body></html>